国: アイルランド
言語: 英語
ソース: HPRA (Health Products Regulatory Authority)
Aciclovir
PCO Manufacturing Ltd.
J05AB01
Aciclovir
200 mg/5ml
Oral suspension
Product subject to prescription which may not be renewed (A)
aciclovir
Authorised
2017-05-19
_ _ PACKAGE LEAFLET: INFORMATION FOR THE USER ZOVIRAX 200 MG/5 ML ORAL SUSPENSION aciclovir READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours. If you get any side effects, talk to your doctor, or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET: 1. What Zovirax is and what it is used for 2. What you need to know before you take Zovirax 3. How to take Zovirax 4. Possible side effects 5. How to store Zovirax 6. Contents of the pack and other information 1. WHAT ZOVIRAX IS AND WHAT IT IS USED FOR Zovirax 200 mg/5 mL Oral Suspension (called ‘Zovirax’ in this leaflet) contains a medicine called aciclovir. This belongs to a group of medicines called antivirals. It works by stopping the growth of viruses. Zovirax 200 mg/5 mL Oral Suspension can be used to: treat chicken-pox treat shingles, and when started right after the rash appears, it can help reduce the nerve pain that can exist after the shingles rash has cleared treat cold sores, genital herpes and other herpes simplex infections (but not to be used to treat herpes simplex infections in newborn infants or severe herpes simplex infections in children whose immune systems work less well which means their bodies are less able to fight infections) stop cold sores and genital herpes returning after you have had them prevent cold sores and genital herpes in people whose immune systems work less well. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE ZOVIRAX DO NOT USE ZOVIRAX IF: you are allergic (hypersensitive) to aciclovir or valaciclovir or any of the other ingredients (listed in Section 6). Do not take Zovirax if the above applies to you. If 完全なドキュメントを読む
Health Products Regulatory Authority 31 May 2021 CRN00CCPH Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Zovirax 200 mg/5 mL oral suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Oral suspension containing 200 mg aciclovir per 5 mL. Excipient(s) with known effect: Sorbitol Liquid (non-crystallising) Methyl parahydroxybenzoate Propyl parahydroxbenzoate Propylene glycol (E1520) For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension. _Product imported from Germany_ Off-white, banana flavoured, suspension 4 CLINICAL PARTICULARS As per PA1077/084/005 5 PHARMACOLOGICAL PROPERTIES As per PA1077/084/005 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Sorbitol Liquid (non-crystallising) (E420) Glycerol Microcrystalline cellulose Carmellose sodium Vanillin Banana flavour (contains propylene glycol (E1520)) Purified water Methyl parahydroxybenzoate (E218) Propyl parahydroxybenzoate (E216) 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product is the date shown on the container and outer package of the product on the market in the country of origin. Diluted: 4 weeks Health Products Regulatory Authority 31 May 2021 CRN00CCPH Page 2 of 2 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. 6.5 NATURE AND CONTENTS OF CONTAINER 62.5 mL amber glass bottle with white, child resistant cap containing a homogenous opaque white, viscous suspension having the taste and odour of banana. The pack contains 2 x 62.5 mL bottles and a double ended 5 mL/2.5 mL spoon. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL For administration of 100 mg dose e.g. 2.5 mL of Zovirax 200 mg/5 mL oral suspension, use the measuring spoon provided or alternatively a graduated syringe. 7 PARALLEL PRODUCT AUTHORISATION HOLDER PCO Manufacturing Ltd. Unit 10, Ashbourne Business Park Rath Ashbourne Co. Meath Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA0465/038/008 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisa 完全なドキュメントを読む